Expression patterns of miR-221 and its target caspase-3 in different cancer cell lines

Molecular Biology Reports

Volumn 41, Issue 9, 2014, Pages 5877-5881

  Ergun, Sercan ^a   Arman, Kaifee ^a   Temiz, Ebru ^a   Bozgeyik, Ibrahim ^b   Yumrutaş, Önder ^b   Safdar, Muhammad ^a   Daǧli, Hasan ^a   Arslan, Ahmet ^a   Oztuzcu, Serdar ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b ADIYAMAN UNIVERSITY   (Turkey)

Author keywords

Apoptosis; Cancer cell line; Caspase 3; MiR 221

Indexed keywords

CASPASE 10; CASPASE 2; CASPASE 3; CASPASE 6; CASPASE 7; CASPASE 8; CASPASE 9; CYTOCHROME C; MICRORNA; MICRORNA 221; CASP3 PROTEIN, HUMAN; MIRN221 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; DISEASE COURSE; ENZYME ACTIVATION; GENE EXPRESSION; HOMEOSTASIS; HUMAN; LIVER CANCER; LUNG CANCER; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RNA TRANSCRIPTION; STOMACH CANCER; UTERINE CERVIX CANCER; GENE EXPRESSION REGULATION; GENETICS; HELA CELL LINE; HEPG2 CELL LINE; METABOLISM; TUMOR CELL LINE; UPREGULATION;

APOPTOSIS; CASPASE 3; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HEP G2 CELLS; HUMANS; MICRORNAS; UP-REGULATION;

EID: 84906939767     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-014-3461-6     Document Type: Article

References (35)

1. Rodriguez-Berriguete G et al (2012) Immunoreactivity to caspase-3, caspase-7, caspase-8, and caspase-9 forms is frequently lost in human prostate tumors. Hum Pathol 43(2):229-237
2. Fulda S (2009) Caspase-8 in cancer biology and therapy. Cancer Lett 281(2):128-133
3. Li J, Yuan J (2008) Caspases in apoptosis and beyond. Oncogene 27(48):6194-6206
4. Logue SE, Martin SJ (2008) Caspase activation cascades in apoptosis. Biochem Soc Trans 36(Pt 1):1-9 (Pubitemid 351269611)
5. Wang ZB, Liu YQ, Cui YF (2005) Pathways to caspase activation. Cell Biol Int 29(7):489-496
6. Jiang X, Wang X (2004) Cytochrome C-mediated apoptosis. Annu Rev Biochem 73:87-106 (Pubitemid 39050364)
7. Creagh EM, Martin SJ (2001) Caspases: cellular demolition experts. Biochem Soc Trans 29(Pt 6):696-702 (Pubitemid 33131763)
8. Shi L et al (2010) MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity. Brain Res 1352:255-264
9. He L, Hannon GJ (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5(7):522-531 (Pubitemid 38868508)
10. le Sage C et al (2007) Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J 26(15):3699-3708
11. Spizzo R et al (2009) SnapShot: microRNAs in cancer. Cell 137(3):586
12. Terasawa K et al (2009) Sustained activation of ERK1/2 by NGF induces microRNA-221 and 222 in PC12 cells. FEBS J 276(12): 3269-3276
13. Gillies JK, Lorimer IA (2007) Regulation of p27Kip1 by miRNA 221/222 in glioblastoma. Cell Cycle 6(16):2005-2009 (Pubitemid 47327888)
14. Felicetti F et al (2008) The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. Cancer Res 68(8):2745-5410
15. Tong AW et al (2009) MicroRNA profile analysis of human prostate cancers. Cancer Gene Ther 16(3):206-216
16. Ambs S et al (2008) Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res 68(15):6162-6170
17. Galardi S et al (2007) miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J Biol Chem 282(32):23716-23724 (Pubitemid 47311902)
18. Lu Q et al (2010) MicroRNA-221 silencing predisposed human bladder cancer cells to undergo apoptosis induced by TRAIL. Urol Oncol 28(6):635-641
19. Gramantieri L et al (2009) MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. Clin Cancer Res 15(16):5073-5081
20. Zhang CZ et al (2010) MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma. Mol Cancer 9:229
21. Sredni ST et al (2010) Upregulation of mir-221 and mir-222 in atypical teratoid/rhabdoid tumors: potential therapeutic targets. Childs Nerv Syst 26(3):279-283
22. Shah MY, Calin GA (2011) MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer. Genome Med 3(8):56
23. Chen WX et al (2013) miR-221/222: promising biomarkers for breast cancer. Tumour Biol 34(3):1361-1370
24. Dentelli P et al (2014) miR-221/222 control luminal breast cancer tumor progression by regulating different targets. Cell Cycle 13(11):1
25. Acunzo M et al (2012) miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222. Oncogene 31(5):634-642
26. Sun T et al (2012) The altered expression of MiR-221/-222 and MiR-23b/-27b is associated with the development of human castration resistant prostate cancer. Prostate 72(10):1093-1103
27. Santos JI et al (2014) Influence of peripheral whole-blood microRNA-7 and microRNA-221 high expression levels on the acquisition of castration-resistant prostate cancer: evidences from in vitro and in vivo studies. Tumour Biol. doi:10.1007/s13277-014-1918-9
28. Sun T et al (2013) MiR-221 promotes the development of androgen independence in prostate cancer cells via downregulation of HECTD2 and RAB1A. Oncogene 1:11
29. Zheng C, Yinghao S, Li J (2012) MiR-221 expression affects invasion potential of human prostate carcinoma cell lines by targeting DVL2. Med Oncol 29(2):815-822
30. Pang Y, Young CY, Yuan H (2010) MicroRNAs and prostate cancer. Acta Biochim Biophys Sin (Shanghai) 42(6):363-369
31. Gordanpour A et al (2011) miR-221 Is down-regulated in TMPRSS2: ERG fusion-positive prostate cancer. Anticancer Res 31(2):403-410
32. Gocze K et al (2013) Unique microRNA expression profiles in cervical cancer. Anticancer Res 33(6):2561-2567
33. Wang M et al (2014) Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: novel biomarkers and a mechanism for gastric cancer. Br J Cancer 110(5):1199-1210
34. Nassirpour R, Mehta PP, Baxi SM, Yin MJ (2013) miR-221 promotes tumorigenesis in human triple negative breast cancer cells. PLoS ONE 8(4):e62170
35. Chen JC, Su YH, Chiu CF, Chang YW, Yu YH, Tseng CF, Chen HA, Su JL (2014) Suppression of dicer increases sensitivity to Gefitinib in human lung cancer cells. Ann Surg Oncol. doi:10.1245/s10434-014-3673-y